BELANO Medical - The Micro­biotics Company
BELANO Medical
The Micro­biotics Company

Press releases

Continuation of business operations and implementation of an M&A process for BELANO medical AG as part of the provisional insolvency administration 

Hennigsdorf b. Berlin, December 6, 2023 – On November 21, the Neuruppin Local Court appointed the Berlin lawyer Dr. Sven Kirchner as provi­sional insol­vency adminis­trator for the assets of BELANO medical AG, based in Hennigsdorf. The management continues business opera­tions without restric­tions under the super­vision of the provi­sional insol­vency adminis­trator in the insol­vency appli­cation procee­dings. An M&A (Mergers & Acqui­si­tions) process is currently being

Conti­nuation of business opera­tions and imple­men­tation of an M&A process for BELANO medical AG as part of the provi­sional insol­vency adminis­tration mehr lesen

read more 

New studies prove microbiome impact in psoriasis 

Acute cream reduces redness and itching - World Psoriasis Day on 29 October Hennigsdorf b. Berlin, 20 October 2023 - In the treatment of psoriasis (psoriasis), the skin micro­biome plays a crucial role. According to current scien­tific publi­ca­tions, bath therapies, for example, which are accom­panied by a re-balancing of the micro­biome, show signi­ficant success in the management of psoriasis. This is pointed out by

New studies prove micro­biome impact in psoriasis mehr lesen

read more 

Chewing gum against gum bleeding and sensitive teeth 

Study proves effec­ti­veness: prevention of periodontal disease Hennigsdorf b. Berlin, 21 September 2023 – The medicinal chewing gum “ventrisana”, developed and distri­buted by BELANO medical AG, was tested in a short term supra-regional user study for its effec­ti­veness against periodon­tosis (periodon­titis), bleeding gums and gingi­vitis. Between May and August, the data of 115 test persons were collected and evaluated who had at least one

Chewing gum against gum bleeding and sensitive teeth mehr lesen

read more 

Christine Lang becomes scientific advisor in Switzerland 

Coope­ration with the Leibniz Institute for Agricul­tural Engineering and Bioeconomy Berlin / Lucerne, August 16, 2023 - Prof. Dr. Christine Lang, Chief Research and Develo­pment Officer of BELANO medical AG, has been appointed to the scien­tific advisory board of Cerefort GmbH. The company, based in the Swiss canton of Nidwalden, develops fermen­ta­tively produced beverages with health-promoting effects. To this end, it also colla­bo­rates with

Christine Lang becomes scien­tific advisor in Switz­erland mehr lesen

read more 

BELANO medical expands international business 

Turnover increases by 30 percent - user studies with 400 parti­ci­pants Hennigsdorf b. Berlin, 20 July 2023 – Despite inflation and the energy crisis, the biotech­nology pioneer BELANO medical AG closed the past financial year with an increase in sales of around 30 percent. Parti­cu­larly in the B2B business, where the company prepares natural micro­biotic active ingre­dients and provides formu­la­tions for other brand labels,

BELANO medical expands inter­na­tional business mehr lesen

read more 

Climate and energy crisis: Industry must be part of the solution 

Berlin, 30 November 2022  Climate change, dwindling resources, energy crisis, declining biodi­versity: the list of global problems and natural risks is long. Prof. Dr. Christine Lang, CSO of BELANO medical AG and professor of micro­biology at Technical University Berlin, has therefore once again highlighted ways in which changing economic behavior can provide solutions to many of these problems. “Our economic thinking must change as

Climate and energy crisis: Industry must be part of the solution mehr lesen

read more 
Scroll to Top